ALENDRONIC ACID EFFERVESCENT TABLETS (Binosto®)
Clinical Indication
Osteoporosis
Comments
For patients that cannot swallow tablets. Not suitable for administration via a feeding tube.
Local guidance
Traffic light changed to green May 2017
Date of classification
August 2016
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.